| Customization: | Available |
|---|---|
| Product Name: | Disposable Dual Chamber 4ml Injection Pen for Gh |
| Valume: | 4ml |
|
Still deciding? Get samples of US$ 7/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Categories | GH Pen for lyophilized powder |
| Classification | Disposable |
| Material | Plastic |
| Min. Dose | 0.01ml |
| Max. Dose | 0.5ml |
| Main Container | 4ml Double-chamber cartridge conforms to ISO11608-3 |
| Compatible Needle Type | Compatible with standard and safety pen needles according to ISO 111608-2 |
Indications
Children: Treatment of growth disturbance due to insufficient secretion of growth hormone (growth hormone deficiency, GHD) and growth disturbance associated with Turner Syndrome or chronic renal insufficiency or in short children born Small for Gestational Age (SGA) with a birth weight and/or length below -2SD, who failed to show catch-up growth by 4 years of age or later.
Prader-Willi syndrome (PWS), for improvement of growth and body composition. The diagnosis of PWS should be confirmed by appropriate genetic testing.
Adults: Replacement therapy in adults with pronounced GH deficiency.
Adult onset: Patients who have severe growth hormone deficiency associated with multiple hormone deficiencies as a result of known hypothalamic or pituitary pathology and who have at least one known deficiency of pituitary hormone not being prolactin.
Childhood Onset: Patients who were growth hormone deficient during childhood as a result of congenital, genetic, acquired, or idiopathic causes.
){kind=link}